ClinConnect ClinConnect Logo
Search / Trial NCT04651686

Effect of Bronchial Artery Protection on Cough After Thoracoscopic Lobectomy

Launched by THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY · Nov 25, 2020

Trial Information

Current as of May 27, 2025

Completed

Keywords

Bronchial Artery Postoperative Cough Three Dimensional Reconstruction Thoracoscopic Surgery

ClinConnect Summary

After pneumonectomy cough on patients' daily life will bring different degrees of adverse effects, so through certain methods to intervene, in order to reduce the incidence of postoperative cough, accelerate the rapid recovery of patients after surgery, improve the quality of life of patients, which should also be worthy of attention of surgeons. In recent years, the research on intervention measures and treatment methods to reduce cough after thoracoscopic lobectomy is mainly focused on drug treatment, traditional Chinese medicine treatment, surgical operation and anesthesia intervention. ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years, no matter male or female;No cough symptoms within two weeks before operation; Lung adenocarcinoma confirmed by pathology;Operation method: thoracoscopic lobectomy + systematic lymph node dissection;Preoperative abdominal B-ultrasound, skull CT / MRI, bone scan or PET / CT to exclude distant metastasis; ECG, lung function, cardiac ultrasound evaluation can tolerate the operation
  • Exclusion Criteria:
  • There were cough caused by respiratory diseases, pharyngitis and rhinitis before operation; Pneumonia was indicated by chest X-ray or chest CT in recent month;Thoracoscopic surgery was converted to thoracotomy;Pulmonary arteriovenous angiography could not be performed in patients with allergy to contrast medium; Patients and their families refused to be enrolled and followed up.

About The First Affiliated Hospital Of Soochow University

The First Affiliated Hospital of Soochow University is a leading medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in various medical disciplines to facilitate high-quality, ethically conducted studies that aim to enhance treatment options and improve patient outcomes. With a commitment to collaboration and scientific rigor, the institution plays a pivotal role in contributing to the global body of medical knowledge while ensuring the highest standards of patient care and safety.

Locations

Suzhou, Jiangsu, China

Patients applied

0 patients applied

Trial Officials

Jun Zhao

Study Director

The First Affiliated Hospital of Soochow University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials